The high mortality rate of patients with end-stage renal disease is mainly caused by the high prevalence of cardiovascular morbidity among this population (1) . Left ventricular hypertrophy (LVH) is very common in patients with end-stage renal failure and is recognized as a powerful independent predictor of death and morbidity in the dialysis population, together with anemia, hypertension, malnutrition, hyperparathyroidism, and an elevated calcium-phosphate product (2) . Ischemic heart disease is usually the result of critical coronary artery disease, but in 27% of hemodialysis patients ischemic symptoms are caused by nonatherosclerotic disease (3) and LVH predispose to ischemic symptoms by reducing coronary reserve.
The structural alterations occur early during the course of renal insufficiency and left ventricular hypertrophy is present in 75% of subjects at the start of dialysis (4) Although the exact pathophysiology of LVH in ESRD is unknown, hypertension, poor extracellular volume control, anemia and uremia have been implicated in the process through the mechanisms of pressure and flow/volume overload (5) .
Causes and types of left ventricular hypertrophy in ESRD patients
Combined volume and pressure overload is the primary cause of LVH in patients with ESRD with other concomitant factors such as: sex, age, renin angiotensin aldosterone system activity (RAAS), level of oxidative stress, etc. Two main types of LVH can be distinguished: concentric and eccentric hypertrophy (6) . • Concentric hypertrophy is primarily characterized by an increase in left ventricular wall thickness and in uremic patients is primarily caused by pressure overload. The stress is applied perpendicularly to the ventricular wall. As a response, myocardial growth occurs with the addition of new sarcomeres in parallel. LV pressure overload results from hypertension, arteriosclerosis (increased arterial stiffness), and occasionally aortic stenosis. In concentric LV hypertrophy there is an increased myocyte thickness and the left ventricular chamber is small, and the diastolic volume is also low. The increase in wall tension is offset by a disproportionate increase in LV wall thickness at normal chamber radius. The thick heart generates diastolic dysfunction because the ventricle is less compliant. • Eccentric hypertrophy is characterized by an increase in left ventricular volume overload. LV volume overload results from salt and water overload, anemia, and the ar teriovenous fistula. Here the stress is applied longitudinally and the growth of the cell occurs also in the same way with the addition of new sarcomeres in series, causing eccentric LV hypertrophy, with increase in myocyte length and increase in LV volume. Volume overload results in an enlargement of ventricular chamber with increased wall thickness to counterbalance increased radius, so that radius/wall thickness ratio remains within normal limits. The ejection fraction is reduced and there is systolic dysfunction. When volume or pressure overload is associated with non hemodynamic factors such as RASS, local inflammation and ischemia, LVH is accompanied by fibrosis and maladaptive hypertrophy which is characterized by the development of myocite death, cardiac fibroblasts proliferation, increase in collagen synthesis and extracelular matrix, cardiomyopathy of overload and heart failure.
Association between extracellular water, hypertension and left ventricular mass in hemodialysis patients
The large majority of patients with chronic renal failure are hypertensive (7, 8) , and the initiation of dialysis does not correct the high BP levels in most of these patients despite the use of antihypertensive drugs. In non-uremic subjects, elevated blood pressure (BP) is the strongest risk factor for LVH and this is also the case in ESRD patients (9) . Chronic renal failure and dialysis patients present with a positive sodium balance and increased ECV. The consequences are systemic hypertension and vascular and cardiac remodelling, especially left ventricular hypertrophy (LVH). Hypertension and LVH are strongly correlated, and their pathogenesis is linked to a number of causes, including fluid and salt overload, hyperkinetic flow secondary to anemia or arteriovenous fistula, hyperparathyroidism, accelerated atherosclerosis due to advanced glycation end-products accumulation, oxidative stress and hyper-homocysteinemia. Regression of LVH with antihypertensive drugs has been clearly established in non-uremic hypertensive patients, but in ESRD patients regression of LVH has been achieved very rarely (10), and is sometimes considered an unavoidably progressive condition (11) . In fact improvement in one of the most important causes of LVH such as early correction of anemia, with epoetin α, on LV mass among patients with CKD showed that maintenance of [Hb] values between 120 and 130 g/L did not have a conclusive effect on LVH either (12) .
Several studies with renal patients have investigated the relationship between hypertension and fluid or salt overload. Hypertension and interdialytic weight gain are clearly associated with left ventricular hypertrophy. Several studies seem to confirm the observation that a reduction in ECW causes normalization of BP in HD patients, or at least a better control of BP (13, 14) . Fluid state and BP in normotensive patients on long HD (8 h) in Tassin were compared with normotensive and hypertensive patients on short HD (3-5 h) at centers in Sweden. Normotension could be achieved independently of the duration and dose (Kt/V urea) of HD, if the control of post-dialysis ECV is adequate (15) . Fagugli et al studied 110 patients on thriceweekly HD to determine whether ECW body content correlates with hypertension and LVH in this patient population. They found that volume overload was linked not only to hypertension but also to LVH. This link with ventricular hypertrophy is consistent with the observation that LVMi was correlated not only with BP but also with ECW. The finding that LVH was eccentric in the majority of patients confirms that the increase in LVMi was related to volume overload, which itself is the cause of both hypertension and LVH (16) .
Could reduction of LVH be achieved by controlling volume overload?
Ozkahya M et al (17) performed a prospective study to investigate the effect of salt restriction and strict volume control on blood pressure and LVH. Nineteen hypertensive patients on chronic hemodialysis (HD) treatment were included in the study. Treatment consisted of 12-h HD per week, during which as much ultrafiltration was applied as possible without an excessive blood pressure (BP) drop. Special attention was given to dietary salt restriction. Normal BP and improvement of cardiac structure, in particular a reduction of LVH could be reached in all patients by intensifying salt restriction and UF.
Lennen et al (18) studied a group of 18 patients with a history of hypertension who were followed for changes in LV anatomy and function over a 6 to 12 month period after initiation of CAPD. The results indicated that CAPD improves LV hypertrophy by normalizing both volume and pressure overload. These effects may prevent deterioration in LV function in patients with still normal LV function, and may improve LV function in patients who already exhibit decreased LV performance. Therefore control of volume overload and blood pressure could be followed by reduction of left ventricular hypertrophy.
Conventional dialysis, LV geometry and hypotensive episodes during hemodialysis
One of the main problems in controlling volume overload in dialysis patients is the tolerance to ultrafiltration in a short period of time. Hypotensive episodes are present in many patients who undergo 4 hours, 3x week dialysis sessions impeding the achievement of dry weight with correct ultrafiltration. Functional implications of LV geometry are of substantial importance and may contribute to explain the negative outcome related to LV hypertrophy.
Why the risk of hypotension increases in the presence of LV hypertrophy? Patients with ESRD and concentric LV hypertrophy have high filling pressure and a near normal or mildly increased LV radius, while myocardial walls are substantially thicker. Preload, therefore, is about normal, because high end-diastolic pressure compensates the increased wall thickness. During dialysis with ultrafiltration there is a reduction in circulating volume and left ventricular filling pressure decreases. If time of volume subtraction is prolonged enough to allow oncotic forces to restore circulating volume, then LV preload can be preserved at a level that can maintain efficient stroke volume and hypotension can be prevented. Patients with ESRD and concentric LV geometr y are unlikely to compensate dialysis-induced reduction of Starling forces with increasing contractility. If reduced preload matches with impaired heart rate response, then drop of cardiac output will result and hypotension occurs (6) .
Hemodialysis schedule and left ventricular hypertrophy
The current standard thrice weekly dialysis poorly controls the high prevalence of cardiovascular morbidity which arises above all from the persistence of hypertension and cardiac hypertrophy. The main reason is the unsatisfactory control of fluid and salt homeostasis arising from the shortness of sessions and lengthy gaps between them, which means insufficient removal and considerable accumulation of fluids. A reduction in interdialytic overload of fluids and salts by shortening the inter-HD period and consequently controlling hypertension more efficiently is achieved with more frequent dialysis. The clinical implication is that more frequent HD sessions, such as daily HD sessions, might provide more adequate prevention of excessive BV expansion cardiovascular overload with prevention or regression of LVH Short daily HD sessions normalized BP in >90% of patients, and the reductions in BP and LVMi were closely correlated with reductions in fluid overload (19, 20) . Fagugli et al performed a randomized two-period crossover study to compare the effect of short daily HD versus standard thrice-weekly dialysis, on BP and LVM in hypertensive patients with end-stage renal disease. A significant reduction in 24-hour BP during DHD was reported. The decrease in BP was accompanied by the withdrawal of antihypertensive therapy in 7 of 8 patients during DHD. LVM index decreased significantly during DHD Extracellular water (ECW) content decreased and correlated with 24-hour SBP and LVM index (21) .
Maduell et al (22) reported a 30% regression of left ventricular mass with short daily on-line hemodiafiltration, a dialysis procedure that associates the more effective dialysis schedule (daily dialysis) with the dialysis modality that offers the highest uremic toxin removal (on-line HDF).
Chan et al (23) reported an observational cohort study with control group looking at the impact on LVH of conversion from conventional hemodialysis to daily nocturnal hemodialysis. They observed regression of LVH after patients on conventional HD were converted to nocturnal HD. In contrast, LV mass did not change in those patients who remained on CHD. Conversion to nocturnal dialysis also resulted in a clinically important reduction in blood pressure and in the prescription of antihypertensive therapy. Post dialysis ECF volume did not change.
Therefore the mode of hemodialysis impacts upon cardiac hypertrophy. More frequent dialysis sessions reduce the magnitude of daily oscillations in ECF and average ECF volume in patients receiving conventional HD is decreased by daily dialysis.
Regression of left ventricular hypertrophy in patients on dialysis: Control of volume overload, high blood pressure or both?
The relationship between volume status and blood pressure (BP) in chronic hemodialysis (HD) patients remains incompletely understood. Specifically, the effect of interdialytic fluid accumulation (or intradialytic fluid removal) on BP is controversial. To assess the effect of volume status on blood pressure, several studies have examined the effect of interdialytic weight gain or intradialytic reduction in body weight on blood pressure; however, the results from these studies are conflicting (24) (25) (26) . Leypoldt et al (27) determined the association of the intradialytic decrease in body weight (as an indicator of interdialytic fluid gain) and the intradialytic decrease in plasma volume (as an indicator of postdialysis volume status) with predialysis and postdialysis BP in a crosssectional analysis of a subset of patients (N = 468) from the Hemodialysis (HEMO) Study. The study shows that volume status influences both predialysis and postdialysis blood pressure. The intradialytic reduction in body weight (or interdialytic fluid gain) is helpful but insufficient to describe volume status and predict blood pressure in chronic hemodialysis patients. Therefore direct and extensive assessment of volume status are needed to clarify the relationship among volume and blood pressure in hemodialysis patients Nevertheless in many reports about the LVH regression in dialysis patients the absence of significant change in post-dialysis ECF volume, and the correlation between the lower SBP and LVMi, point to a significant role for hyper tension in the pathogenesis of LVH in this population. We have already discuss the changes in ventricular architecture in this ESRD population. Studies of hypertensive patients with primary hypertension implicate blood pressure load in the development of concentric LVH (increased wall thickness with increased LV mass), and in addition, increased plasma volume in those with eccentric LVH (normal wall thickness with increased LV mass).
Chang et al (23) reported that their patients at baseline had primarily eccentric LVH. Following the conversion to NHD, there were significant reductions in both LV wall thickness and chamber volume, suggesting a role for reductions in both BP and intravascular volume in this process of regression and reverse remodeling. They suggest that more continuous modes of renal replacement therapy may promote regression of LVH likely through control in both volume and pressure management.
Dietary salt restriction and left ventricular hypertrophy in dialysis patients
Sodium remains the major indicator of body tonicity and determines the distribution of water across the intracellular-extracellular boundary, subsequent cell volume, thirst, and, among patients with renal insufficiency, systemic blood pressure. Numerous reports in general population, based on epidemiologic and demographic data, have pointed to the relationship between sodium intake and hypertension. In chronic renal failure patients expansion of extracellular volume can cause hypertension although the pathogenesis of elevated blood pressure in ESRD is more complex and may be the result of multiple factors acting simultaneously or individually. There is overwhelming evidence that favors an important role for extracellular volume and sodium balance in the hypertension of ESRD. Therefore the primary goal in the treatment of hypertension should be to attain a dryweight and maintain volume control through limiting salt and fluid intake and ultrafiltration of excess fluids.
There is a first step in the control of all these factors, VH, blood volume overload and hypertension in dialysis patients: salt restriction. A simple reduction of three g in salt intake observed by Maduell et all was beneficial in interdialytic weight gain, dialysis tolerance and blood pressure control (27) . Shaldon (29) points out very clearly that throughout the world today dialysis patients are being incorrectly managed with respect to dietary salt intake and the concentration of dialysate sodium to control hypertension. They evaluate the role of a salt restriction of 5-6 g/day (no added salt in cooking and avoidance of all foods that taste salty) combined with a sodium dialysate of 135 mmol/L, (following patient compliance; with substantial reduction in post-dialysis thirst), without any increase in dialysis time (4-5 h), in a group of selected hypertensive patients who had been treated with hemodialysis from 1 to 18 years. The results suggested that in compliant patients, a mean ar terial pressure of less than 100 mmHg could be obtained and maintained by a simple reduction in salt intake, without any drug therapy or reduction in dry body weight (30) .
The benefit of salt restriction in the hypertensive dialysis patient on blood pressure control and blood volume overload is clear. The consequences of imposing a salt restricted diet upon the patient as a first therapeutical prescription will definitively be followed by a decrease in left ventricular hypertrophy and in the high prevalence of cardiovascular morbidity.
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